TRQZX
Price
$99.69
Change
-$0.91 (-0.90%)
Updated
Jun 23 closing price
Net Assets
22.46B
VYRBX
Price
$11.82
Change
-$0.26 (-2.15%)
Updated
Jun 22 closing price
Net Assets
204.08M
Interact to see
Advertisement

TRQZX vs VYRBX

TRQZX vs VYRBX Comparison Chart in %
View a ticker or compare two or three
VS
TRQZX vs. VYRBX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRQZX is a Buy and VYRBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRQZX has more cash in the bank: 22.5B vs. VYRBX (204M). TRQZX pays higher dividends than VYRBX: TRQZX (0.72) vs VYRBX (0.61). TRQZX was incepted earlier than VYRBX: TRQZX (6 years) vs VYRBX (10 years). VYRBX (0.99) is less costly to investors than TRQZX (0.61). TRQZX is a more actively managed with annual turnover of: 31.50 vs. VYRBX (13.00). TRQZX (0) and VYRBX (0) have matching initial minimum investment requirements. TRQZX annual gain was more profitable for investors over the last year : 0.80 vs. VYRBX (-51.81). TRQZX return over 5 years is better than : -17.08 vs. VYRBX (-64.50).
TRQZXVYRBXTRQZX / VYRBX
Total Expense Ratio0.000.99-
Annual Report Gross Expense Ratio0.610.9962%
Fund Existence6 years10 years-
Gain YTD2.319-37.988-6%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets22.5B204M11,029%
Annual Yield % from dividends0.720.61119%
Returns for 1 year0.80-51.81-2%
Returns for 3 years4.82-53.56-9%
Returns for 5 years-17.08-64.5026%
Returns for 10 yearsN/A-57.37-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTMKX54.91N/A
N/A
Fidelity Advisor Focused Em Mkts M
NGDLX31.01N/A
N/A
Neuberger Large Cap Growth Inst
RRRZX23.95N/A
N/A
DWS RREEF Real Estate Securities R6
MOJAX19.37N/A
N/A
DF Tactical Momentum Fund A
HDIVX20.91-0.39
-1.83%
Janus Henderson International Div I